Targeted drugs that attack the genetic machinery of cancer with laser-like precision are, in a select group of patients, melting tumors away, often with few side effects. The problem is, almost invariably, these medications eventually stop working. That is fueling a mad dash to discover why cancers become resistant to so-called smart drugs and to develop new therapies - or combinations of drugs ...